Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Medpace Holdings, Inc. - Common Stock (NQ:MEDP)

460.59 -5.13 (-1.10%)
Streaming Delayed Price Updated: 10:21 AM EDT, Aug 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Medpace Holdings, Inc. - Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2021 Financial Results on February 14, 2022
From Medpace Holdings, Inc.
Via Business Wire
5 Stocks Insiders Are Selling
When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to... 
Via Benzinga
This Diversified Healthcare Stock Offers Explosive Biotech-Like Growth
Since its IPO five years ago, this clinical trial specialist is up over 700%. 
Via The Motley Fool
Topics Initial Public Offering
PerkinElmer Stock, Already Highly Rated, Perks Up Further Amid Brisk Sales, Profit Growth For Its Instruments
A Relative Strength Rating upgrade for PerkinElmer shows improving technical performance. Will it continue? 
Via Investor's Business Daily
Thermo Fisher Stock Strength Rating Climbs To 81; Medical Devices Maker Shows Market Leadership
Thermo Fisher Scientific shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 77 to 81. 
Via Investor's Business Daily
60 Biggest Movers From Yesterday
Gainers Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares surged 308.1% to settle at $9.59 on Tuesday after the company signed an agreement with Waas Group for the... 
Via Benzinga
Medpace Holdings, Inc. Common Stock (MEDP) Q3 2021 Earnings Call Transcript
MEDP earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Ocugen (NASDAQ:OCGN) shares increased by 26.44% to $11.81 during Tuesday's regular session. Trading volume for this security as of 12:30 EST is 135.6 million,... 
Via Benzinga
40 Stocks Moving In Tuesday's Mid-Day Session
Gainers Wallbox N.V. (NYSE: WBX) shares climbed 54.5% to $17.16. Uber and Wallbox N.V. disclosed a strategic partnership to simplify the transition to EVs for Bay Area ride... 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Medpace Hldgs (NASDAQ:MEDP) shar... 
Via Benzinga
Medpace Holdings, Inc. Reports Third Quarter 2021 Results
From Medpace Holdings, Inc.
Via Business Wire
Earnings Outlook For Medpace Hldgs
Medpace Hldgs (NASDAQ:MEDP) is set to give its latest quarterly earnings report on Monday, 2021-10-25. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
Medpace Hldgs Insider Trades $12 Million In Company Stock
Susan E Burwig, Exec. Vp And Operations at Medpace Hldgs (NASDAQ:MEDP), made a large insider sell on September 3, according to a new SEC filing. What Happened: A Form 4 filing... 
Via Benzinga
Topics Regulatory Compliance
Medpace Holdings, Inc. to Report Third Quarter 2021 Financial Results on October 25, 2021
From Medpace Holdings, Inc.
Via Business Wire
Earnings Scheduled For October 25, 2021
Companies Reporting Before The Bell • HNI (NYSE:HNI) is expected to report quarterly earnings at $0.43 per share on revenue of $592.14 million. • Travelzoo (... 
Via Benzinga
Medpace Stock Earns Relative Strength Rating Upgrade; Remains In Buy Zone
Ohio-based Medpace stock saw its Relative Strength Rating enter the 80-plus level while it stays in a buy zone. 
Via Investor's Business Daily
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc... 
Via Benzinga
Medpace Holdings, Inc. to Present at Baird’s Global Healthcare Conference
From Medpace Holdings, Inc.
Via Business Wire
A Look Into Medpace's Price Over Earnings
In the current market session, Medpace Hldgs Inc. (NASDAQ:MEDP) is trading at $179.28, after a 0.76% drop. However, over the past month, the stock increased by 2.01... 
Via Benzinga
Medpace Stock Shows Rising Price Performance With Jump To 83 RS Rating
Medpace sees its Relative Strength Rating reach the 80-plus level. 
Via Investor's Business Daily
Medpace Holdings, Inc. Common Stock (MEDP) Q2 2021 Earnings Call Transcript
MEDP earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Medpace Hldgs: Q2 Earnings Insights
Shares of Medpace Hldgs (NASDAQ:MEDP) were flat in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 65.62% year over year... 
Via Benzinga
Medpace Holdings, Inc. Announces Senior Leadership Changes
From Medpace Holdings, Inc.
Via Business Wire
Medpace Holdings, Inc. Reports Second Quarter 2021 Results
From Medpace Holdings, Inc.
Via Business Wire
Earnings Scheduled For July 26, 2021
Companies Reporting Before The Bell • Otis Worldwide (NYSE:OTIS) is estimated to report quarterly earnings at $0.71 per share on revenue of $3.45 billion. •... 
Via Benzinga
Earnings Outlook For Medpace Hldgs
Medpace Hldgs (NASDAQ:MEDP) announces its next round of earnings this Monday, July 26. Here is Benzinga's everything-that-matters guide for this Monday's Q2 earnings announcement... 
Via Benzinga
Medpace Holdings, Inc. to Report Second Quarter 2021 Financial Results on July 26, 2021
From Medpace Holdings, Inc.
Via Business Wire
3 Top Healthcare Stocks to Buy Right Now
These three healthcare stocks have proven that growth and long-term trends are on their side. 
Via The Motley Fool
Medpace Holdings, Inc. to Present at the Jefferies Virtual Healthcare Conference
From Medpace Holdings, Inc.
Via Business Wire
Cramer Advises Viewers On Fastly, Wells Fargo And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said he expects more downgrades for Fastly Inc (NYSE: FSLY) on Thursday. He can't recommend the stock. Cramer... 
Via Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.